Scroll To Top
Health

FDA approves
generic AZT for U.S. sale

FDA approves
generic AZT for U.S. sale

Approval allows first foreign-made generic anti-HIV drug in U.S. market.

Sorry to interrupt...
But we wanted to take a moment to thank you for reading. Your support makes original LGBTQ+ reporting possible. Help us hold Trump accountable.

The Food and Drug Administration on Friday granted approval to a generic version of AZT made by Indian drugmaker Aurobindo Pharma for sale in the United States. The approval marks the first time a generic anti-HIV medication made by a foreign firm has been approved for U.S. sale. The U.S. patent on AZT, sold under the brand name Retrovir, expired in September. Aurobindo Pharma's cheaper version of the medication is expected to be available in the U.S. later this month. (The Advocate)

The Advocates with Sonia BaghdadyOut / Advocate Magazine - Alan Cumming and Jake Shears

From our Sponsors

Most Popular

Latest Stories

Outtraveler Staff